Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Carlomagno

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancerValentina De Falco, Francesca Carlomagno, Hong-Yu Li, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Molecular mechanisms of RET activation in human cancerMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluationBrendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
Endocrinology|August 28, 2004
Minireview: RET: normal and abnormal functionsMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 18, 2007
New therapeutic approaches to treat medullary thyroid carcinomaMartin Schlumberger, Francesca Carlomagno, Eric Baudin, et al.
Cancer Research|February 19, 2009
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinomaTito Claudio Nappi, Paolo Salerno, Horst Zitzelsberger, et al.
Investigative Ophthalmology & Visual Science|October 27, 2007
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damageMariacarmela Allocca, Umberto Di Vicino, Marco Petrillo, et al.
Cell Reports|August 17, 2022
NCOA4 links iron bioavailability to DNA metabolismGiorgia Federico, Federica Carrillo, Francesca Dapporto, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological blockLuigi Alfano, Teresa Guida, Livia Provitera, et al.
Journal of the National Cancer Institute|March 2, 2006
BAY 43-9006 inhibition of oncogenic RET mutantsFrancesca Carlomagno, Suresh Anaganti, Teresa Guida, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancerValentina De Falco, Francesca Carlomagno, Hong-Yu Li, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Molecular mechanisms of RET activation in human cancerMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.
European Journal of Medicinal Chemistry|September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluationBrendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
Endocrinology|August 28, 2004
Minireview: RET: normal and abnormal functionsMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 18, 2007
New therapeutic approaches to treat medullary thyroid carcinomaMartin Schlumberger, Francesca Carlomagno, Eric Baudin, et al.
Cancer Research|February 19, 2009
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinomaTito Claudio Nappi, Paolo Salerno, Horst Zitzelsberger, et al.
Investigative Ophthalmology & Visual Science|October 27, 2007
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damageMariacarmela Allocca, Umberto Di Vicino, Marco Petrillo, et al.
Cell Reports|August 17, 2022
NCOA4 links iron bioavailability to DNA metabolismGiorgia Federico, Federica Carrillo, Francesca Dapporto, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological blockLuigi Alfano, Teresa Guida, Livia Provitera, et al.
Journal of the National Cancer Institute|March 2, 2006
BAY 43-9006 inhibition of oncogenic RET mutantsFrancesca Carlomagno, Suresh Anaganti, Teresa Guida, et al.
Pageof 7